Keryx Biopharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (29)

Latest Posts

About This Stock More About This Stock
Back On Track
Article By: Warren Bevan
Tuesday, September 27, 2016 10:26 PM EDT
Stocks staged a nice comeback after the first presidential debate Monday evening. I continue to see stocks acting great, as they should, in a bull market.
In this article: REN, AMZN, KERX, SPY, BABA, MOMO, ACIA, LITE, TWLO
Read
Invest Like Seth Klarman: Paypal Holdings Inc., Keryx Biopharmaceuticals, Micron Technology, Inc.
Article By: TipRanks
Tuesday, January 19, 2016 11:03 AM EDT
In the 3Q, Klarman’s hedge fund, Baupost Group, had a rough quarter, losing 22.42% of its value compared to the S&P 500 which lost about 7% in the same time period.
In this article: MU, KERX, PYPL
Read
Thursday Morning’s Pre-Market Insights: KERX, SNDK, QCOM, And CRUS
Article By: TipRanks
Thursday, July 23, 2015 8:29 AM EDT
Cirrus Logic, Inc. shares spiked more than 20% in pre-market trading to $33.85m after beating estimates on solid first quarter earnings. The company posted first quarter revenue of $282.6m, surpassing the consensus estimate of $260.73m.
In this article: CRUS, QCOM, SNDK, KERX
Read
Brean Capital Weighs In On Keryx Biopharmaceuticals Inc. And Rockwell Medical Inc. In Light Of Dialysis Drugs
Article By: TipRanks
Tuesday, June 23, 2015 12:47 PM EDT
On June 22, Brean Capital analyst Jonathan Aschoff weighed in on Keryx Biopharmaceuticals Inc. and Rockwell Medical Inc. to provide commentary on both companies’ dialysis drugs.
In this article: KERX, RMTI
Read
Analysts Positive On Keryx Biopharmaceuticals, Inc. Despite Weak Prescription Data
Article By: TipRanks
Tuesday, May 5, 2015 11:24 AM EDT
Keryx posted total revenue of $1.175 million, including 1,218 prescriptions filled for Auryxia in the quarter.
In this article: KERX
Read

PARTNER HEADLINES

Latest Tweets for $KERX

No tweets yet!